[Insulin resistance in children]

Joanna Witek1, Przemysław Witek, Ewa Pańkowska

  • 1Instytut Matki i Dziecka w Warszawie. joanna.witek@imid.med.pl

Insights

Insulin resistance, marked by reduced tissue sensitivity to insulin, is rising globally. Key factors include diet and inactivity, leading to serious health issues like type 2 diabetes in children.

Area of Science:

  • Pediatric Endocrinology
  • Metabolic Disorders
  • Public Health

Context:

  • Insulin resistance is increasing globally, posing diagnostic challenges in children.
  • Genetic and environmental factors, including poor diet and low physical activity, contribute significantly.
  • Visceral adipose tissue plays a crucial role due to its endocrine activity and adverse metabolic effects.

Purpose:

  • To review risk factors for insulin resistance in children.
  • To discuss direct and indirect assessment methods for insulin resistance.
  • To outline primary and secondary prevention strategies, including lifestyle and pharmacological interventions.

Summary:

  • Insulin resistance, characterized by decreased tissue sensitivity to insulin and impaired glucose uptake, is a growing concern.
  • Consequences in children include type 2 diabetes, dyslipidemia, hypertension, nonalcoholic steatohepatitis, sleep apnea, and polycystic ovary syndrome (PCOS).
  • Prevention focuses on dietary changes, increased physical activity, and, when necessary, pharmacotherapy.

Impact:

  • Highlights the critical need for early detection and intervention in pediatric populations.
  • Emphasizes the link between lifestyle factors and severe metabolic and cardiovascular diseases in children.
  • Provides a comprehensive overview for clinicians and researchers on managing pediatric insulin resistance.

Related Concept Videos

Insulin: Dosing Regimen and Adverse Effects01:16

Insulin: Dosing Regimen and Adverse Effects

Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
Type II Diabetes II: Pathophysiology01:24

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
Type II Diabetes I: Introduction01:26

Type II Diabetes I: Introduction

Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
Type I Diabetes II: Pathophysiology01:26

Type I Diabetes II: Pathophysiology

Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...